Abstract
Breast cancer is the most common malignant neoplasm in women worldwide and one of the leading causes of death for women in developed countries. The main treatment strategy is chemotherapy followed by radiotherapy, but resistance is frequent, resulting in a 46% rate of metastasis, 25% recurrence after surgery and 75% mortality. The use of monoclonal antibodies to inhibit immune checkpoints…